Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Oct;75(10):908-912.
doi: 10.1136/thoraxjnl-2020-214703. Epub 2020 Aug 5.

Lung Screen Uptake Trial: results from a single lung cancer screening round

Affiliations
Observational Study

Lung Screen Uptake Trial: results from a single lung cancer screening round

Mamta Ruparel et al. Thorax. 2020 Oct.

Abstract

The Lung Screen Uptake Trial tested a novel invitation strategy to improve uptake and reduce socioeconomic and smoking-related inequalities in lung cancer screening (LCS) participation. It provides one of the first UK-based 'real-world' LCS cohorts. Of 2012 invited, 1058 (52.6%) attended a 'lung health check'. 768/996 (77.1%) in the present analysis underwent a low-dose CT scan. 92 (11.9%) and 33 (4.3%) participants had indeterminate pulmonary nodules requiring 3-month and 12-month surveillance, respectively; 36 lung cancers (4.7%) were diagnosed (median follow-up: 1044 days). 72.2% of lung cancers were stage I/II and 79.4% of non-small cell lung cancer had curative-intent treatment.

Keywords: imaging/CT MRI etc; lung cancer.

PubMed Disclaimer

Conflict of interest statement

Competing interests: SMJ, MR, JLD, CH, ST and HH are supported by funding for a large trial of low dose CT screening, called the ‘SUMMIT Study’ by GRAIL Inc. SLQ and NN collaborate on the SUMMIT Study. SMJ has received honoraria from AstraZeneca, BARD1 Bioscience and Janssen for being an Advisory Board Expert and travel to a US conference. SMJ received grant funding from Owlstone for a separate research study and has a family member who has a financial association with AstraZeneca. MR has received travel funding for a conference from Takeda and an honorarium for planning and speaking at educational meetings from AstraZeneca.

Figures

Figure 1
Figure 1
Flow chart of invitees and participants demonstrating numbers identified, invited, enrolled, eligible for LDCT and that completed a LDCT examination. DNA, did not attend; LDCT, low-dose CT; LLP, Liverpool Lung Project; MDT, multidisciplinary team; PLCOm2012, Prostate, Lung, Colorectal and Ovarianstudy model 2012; USPSFT, United States Preventive Services Task Force.

References

    1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed
    1. de Koning HJ, van der Aalst CM, de Jong PA, et al. . Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020;382:503–13. 10.1056/NEJMoa1911793 - DOI - PubMed
    1. Pastorino U, Silva M, Sestini S, et al. . Prolonged lung cancer screening reduced 10-year mortality in the mild trial: new confirmation of lung cancer screening efficacy. Ann Oncol 2019;30:1162–9. 10.1093/annonc/mdz117 - DOI - PMC - PubMed
    1. Kovalchik SA, Tammemagi M, Berg CD, et al. . Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245–54. 10.1056/NEJMoa1301851 - DOI - PMC - PubMed
    1. Black WC, Gareen IF, Soneji SS, et al. . Cost-effectiveness of CT screening in the National lung screening trial. N Engl J Med Overseas Ed 2014;371:1793–802. 10.1056/NEJMoa1312547 - DOI - PMC - PubMed

Publication types